Indication
Clostridium septicemia
Clostridium septicemia is a life-threatening systemic infection defined by the invasion and proliferation of anaerobic, spore-forming *Clostridium* species—most frequently *Clostridium perfringens* or *Clostridium septicum*—within the bloodstream. Read more about Clostridium septicemia
56 drugs 52 manufacturers
Drugs that treat it
Common Clostridium septicemia therapies.
METRONIDAZOLE
METRONIDAZOLE
METRONIDAZOLE
METRONIDAZOLE
METRONIDAZOLE
METRONIDAZOLE
METRONIDAZOLE (metronidazole in sodium chloride)
METRONIDAZOLE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonClostridium septicemia is a life-threatening systemic infection defined by the invasion and proliferation of anaerobic, spore-forming *Clostridium* species—most frequently *Clostridium perfringens* or *Clostridium septicum*—within the bloodstream.
It primarily affects the cardiovascular and hematologic systems, frequently arising from deep soft-tissue trauma, intra-abdominal or hepatobiliary pathologies, gynecologic infections, or underlying conditions such as diabetes mellitus and gastrointestinal or hematologic malignancies.
Pathophysiologically, the condition is driven by the rapid release of potent exotoxins that cause massive intravascular hemolysis, gas production in tissues, profound leukocytosis, rapidly progressive septic shock, and multiorgan failure.
- nih.gov
Clostridium septicemia is a life-threatening systemic infection defined by the invasion and proliferation of anaerobic, spore-forming *Clostridium* species—most frequently *Clostridium perfringens* or *Clostridium septicum*—within the bloodstream It primarily affects the cardiovascular and hematologic systems, frequently arising from deep soft-tissue trauma, intra-abdominal or hepatobiliary pathologies, gynecologic infections, or underlying conditions such as diabetes mellitus and gastrointestin...
- nih.gov
Clostridium septicemia is a life-threatening systemic infection defined by the invasion and proliferation of anaerobic, spore-forming *Clostridium* species—most frequently *Clostridium perfringens* or *Clostridium septicum*—within the bloodstream
- nih.gov
It primarily affects the cardiovascular and hematologic systems, frequently arising from deep soft-tissue trauma, intra-abdominal or hepatobiliary pathologies, gynecologic infections, or underlying conditions such as diabetes mellitus and gastrointestinal or hematologic malignancies
- nih.gov
It primarily affects the cardiovascular and hematologic systems, frequently arising from deep soft-tissue trauma, intra-abdominal or hepatobiliary pathologies, gynecologic infections, or underlying conditions such as diabetes mellitus and gastrointestinal or hematologic malignancies
- nih.gov
Pathophysiologically, the condition is driven by the rapid release of potent exotoxins that cause massive intravascular hemolysis, gas production in tissues, profound leukocytosis, rapidly progressive septic shock, and multiorgan failure
- thebloodproject.com
Pathophysiologically, the condition is driven by the rapid release of potent exotoxins that cause massive intravascular hemolysis, gas production in tissues, profound leukocytosis, rapidly progressive septic shock, and multiorgan failure
Personalize your experience
Follow Clostridium septicemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.